首页 > 最新文献

Journal of Indian College of Cardiology最新文献

英文 中文
Gerbode defect – Percutaneous closure of three cases and a brief review of literature Gerbode缺损:经皮修补3例及文献回顾
Pub Date : 2022-04-01 DOI: 10.4103/jicc.jicc_9_21
M. Roy, Debasree Gangopadhyay, Siddhartha Saha, Sushil Sukla., P. Sinha
Gerbode defect is very rare cardiac abnormality accounting for <1% of cardiac defects. Historically treated by open heart surgery, many authors have now popularized the concept of percutaneous closure of such defects by various devices. We report three such cases and provide a brief review of the literature.
Gerbode缺损是一种非常罕见的心脏畸形,占心脏缺损的1%以下。历史上通过心内直视手术治疗,许多作者现在已经普及了通过各种装置经皮闭合这类缺陷的概念。我们报告了三个这样的病例,并提供了一个简短的文献回顾。
{"title":"Gerbode defect – Percutaneous closure of three cases and a brief review of literature","authors":"M. Roy, Debasree Gangopadhyay, Siddhartha Saha, Sushil Sukla., P. Sinha","doi":"10.4103/jicc.jicc_9_21","DOIUrl":"https://doi.org/10.4103/jicc.jicc_9_21","url":null,"abstract":"Gerbode defect is very rare cardiac abnormality accounting for <1% of cardiac defects. Historically treated by open heart surgery, many authors have now popularized the concept of percutaneous closure of such defects by various devices. We report three such cases and provide a brief review of the literature.","PeriodicalId":100789,"journal":{"name":"Journal of Indian College of Cardiology","volume":"62 1","pages":"71 - 75"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76968858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Difficulties with optical coherence tomography in assessment of an in-stent restenosis lesion 光学相干断层扫描在评估支架内再狭窄病变中的困难
Pub Date : 2022-04-01 DOI: 10.4103/jicc.jicc_31_21
R. Subrahmanya Sarma, Gopala Koduru, P. Koduru, Somasekahr Ghanta, Sarada Chowdary Parvathaneni, Raghuram Palaparti, Dasarath Boppana, V. Swarajyam, Y. Srinivas, Y. Sasidhar, M. Prasad
In-stent restenosis (ISR) is a critical drawback of coronary stents, although initially described as benign, guidelines both support the use of intravascular imaging in the diagnosis and treatment of stent failure (Class IIa); however, our case highlights the limitation of optical coherence tomography in the assessment of the ISR (stent failure), it also highlights the association of self-limited severe acute respiratory syndrome coronavirus-2 illness and an acute coronary syndrome ISR presentation.
支架内再狭窄(ISR)是冠状动脉支架的一个关键缺陷,尽管最初被描述为良性的,但指南都支持在支架失效的诊断和治疗中使用血管内成像(IIa类);然而,我们的病例强调了光学相干断层扫描在评估ISR(支架失效)方面的局限性,它也强调了自限性严重急性呼吸系统综合征冠状病毒-2疾病与急性冠状动脉综合征ISR表现的相关性。
{"title":"Difficulties with optical coherence tomography in assessment of an in-stent restenosis lesion","authors":"R. Subrahmanya Sarma, Gopala Koduru, P. Koduru, Somasekahr Ghanta, Sarada Chowdary Parvathaneni, Raghuram Palaparti, Dasarath Boppana, V. Swarajyam, Y. Srinivas, Y. Sasidhar, M. Prasad","doi":"10.4103/jicc.jicc_31_21","DOIUrl":"https://doi.org/10.4103/jicc.jicc_31_21","url":null,"abstract":"In-stent restenosis (ISR) is a critical drawback of coronary stents, although initially described as benign, guidelines both support the use of intravascular imaging in the diagnosis and treatment of stent failure (Class IIa); however, our case highlights the limitation of optical coherence tomography in the assessment of the ISR (stent failure), it also highlights the association of self-limited severe acute respiratory syndrome coronavirus-2 illness and an acute coronary syndrome ISR presentation.","PeriodicalId":100789,"journal":{"name":"Journal of Indian College of Cardiology","volume":"20 11 1","pages":"76 - 78"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83887307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left ventricular global longitudinal strain in patients with chronic kidney disease with and without renal replacement therapy: A cross-sectional study 接受或不接受肾脏替代治疗的慢性肾病患者左心室整体纵向应变:一项横断面研究
Pub Date : 2022-04-01 DOI: 10.4103/jicc.jicc_48_21
R. Sankaran, S. Ramalakshmi, Manish Babbu Uppupetai Ganeshbabbu, M. Jayakumar, M. Ramamurthy, V. Balakrishnan, N. Senguttuvan
Background: Cardiovascular disease is the leading cause of mortality among patients with chronic kidney disease (CKD). Hemodialysis treatment is associated with an increased risk of developing left ventricular (LV) dysfunction. LV global longitudinal strain (GLS) has emerged as a sensitive parameter in evaluating LV function in patients with CKD. We aimed to assess cardiac function using two-dimensional (2D) echocardiogram, 2D speckle-tracking echocardiogram (2DSTE), and traditional ejection fraction (EF) in patients undergoing hemodialysis. Methods: A cross-sectional study was conducted for 3 months in patients with CKD at a tertiary care center in Southern India. Patients were subjected to conventional 2DSTE and evaluated for LV ejection fraction (LVEF), GLS, pulmonary systolic blood pressure, and the degree of tricuspid regurgitation. Results: Among 100 patients with CKD, 54.3% underwent hemodialysis, and 26.7% on drug therapy had impaired LV GLS. The LVEF was normal in 61.4% of patients undergoing hemodialysis and 86.7% of patients on drug therapy. Proportion of patients undergoing hemodialysis were significantly high with moderate-to-severe pulmonary hypertension (21.4%), moderate-to-severe tricuspid regurgitation (21.4%), and mild-to-moderate EF (37.1%) compared to respective patients on drug therapy. Pulmonary hypertension and abnormal EF are significantly associated with lesser GLS in patients undergoing hemodialysis. Conclusions: This study indicated that patients undergoing hemodialysis are at higher risk for impaired LV GLS. The GLS by 2DSTE can act as an early diagnostic tool for this high-risk patient group. Thus, regular cardiac screening is required for early detection, and treatment in patients undergoing hemodialysis with risk of LV dysfunction.
背景:心血管疾病是慢性肾脏疾病(CKD)患者死亡的主要原因。血液透析治疗与左室(LV)功能障碍的风险增加有关。左室整体纵向应变(GLS)已成为评估CKD患者左室功能的敏感参数。我们的目的是利用二维超声心动图(2D)、二维斑点跟踪超声心动图(2DSTE)和传统射血分数(EF)评估血液透析患者的心功能。方法:在印度南部三级保健中心对CKD患者进行了为期3个月的横断面研究。患者接受常规2DSTE检查,评估左室射血分数(LVEF)、GLS、肺收缩压和三尖瓣反流程度。结果:100例CKD患者中,54.3%接受血液透析治疗,26.7%接受药物治疗的患者左室GLS受损。61.4%的血液透析组和86.7%的药物治疗组LVEF正常。中重度肺动脉高压(21.4%)、中重度三尖瓣反流(21.4%)和轻中度EF(37.1%)患者接受血液透析的比例明显高于药物治疗的患者。在接受血液透析的患者中,肺动脉高压和异常EF与较小的GLS显著相关。结论:本研究表明,接受血液透析的患者左室GLS受损的风险较高。2DSTE的GLS可以作为这一高危患者群体的早期诊断工具。因此,对于有左室功能障碍风险的血液透析患者,需要定期进行心脏筛查,以便早期发现和治疗。
{"title":"Left ventricular global longitudinal strain in patients with chronic kidney disease with and without renal replacement therapy: A cross-sectional study","authors":"R. Sankaran, S. Ramalakshmi, Manish Babbu Uppupetai Ganeshbabbu, M. Jayakumar, M. Ramamurthy, V. Balakrishnan, N. Senguttuvan","doi":"10.4103/jicc.jicc_48_21","DOIUrl":"https://doi.org/10.4103/jicc.jicc_48_21","url":null,"abstract":"Background: Cardiovascular disease is the leading cause of mortality among patients with chronic kidney disease (CKD). Hemodialysis treatment is associated with an increased risk of developing left ventricular (LV) dysfunction. LV global longitudinal strain (GLS) has emerged as a sensitive parameter in evaluating LV function in patients with CKD. We aimed to assess cardiac function using two-dimensional (2D) echocardiogram, 2D speckle-tracking echocardiogram (2DSTE), and traditional ejection fraction (EF) in patients undergoing hemodialysis. Methods: A cross-sectional study was conducted for 3 months in patients with CKD at a tertiary care center in Southern India. Patients were subjected to conventional 2DSTE and evaluated for LV ejection fraction (LVEF), GLS, pulmonary systolic blood pressure, and the degree of tricuspid regurgitation. Results: Among 100 patients with CKD, 54.3% underwent hemodialysis, and 26.7% on drug therapy had impaired LV GLS. The LVEF was normal in 61.4% of patients undergoing hemodialysis and 86.7% of patients on drug therapy. Proportion of patients undergoing hemodialysis were significantly high with moderate-to-severe pulmonary hypertension (21.4%), moderate-to-severe tricuspid regurgitation (21.4%), and mild-to-moderate EF (37.1%) compared to respective patients on drug therapy. Pulmonary hypertension and abnormal EF are significantly associated with lesser GLS in patients undergoing hemodialysis. Conclusions: This study indicated that patients undergoing hemodialysis are at higher risk for impaired LV GLS. The GLS by 2DSTE can act as an early diagnostic tool for this high-risk patient group. Thus, regular cardiac screening is required for early detection, and treatment in patients undergoing hemodialysis with risk of LV dysfunction.","PeriodicalId":100789,"journal":{"name":"Journal of Indian College of Cardiology","volume":"59 1","pages":"60 - 65"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78688217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Understanding the status of the Egyptian coronary lesions: Lesion location and vulnerability 了解埃及冠状动脉病变的状况:病变的位置和易损性
Pub Date : 2022-04-01 DOI: 10.4103/jicc.jicc_17_21
I. El-Dosouky, B. Nashy, H. Abomandour
Background: High-probability zones of coronary thrombosis may exist along the coronary tree. We aimed to determine the nature and distribution of significant coronary lesions among our patients. Methods: This study included 529 patients, for whom coronary angiography was done for suspected or proved coronary artery disease (CAD), they were divided into three groups according to the distribution of the coronary lesions: left anterior descending (LAD) group (n = 305) with significant LAD lesion, left circumflex (LCx) group (n = 148) with significant LCx lesion and right coronary artery (RCA) group (n = 181) with significant RCA lesion. Results: One hundred and sixty-nine (31.9%) had nonsignificant lesion, 166 (31.4%) had single-vessel disease, with significantly higher incidence of significant LAD lesion 305 (57.5%) which were proximal 52.4%, LAD lesions were more prone to be the culprit vessel 47.5%, LCx was the least vessel with significant lesion 148 (27.9%), and the least to be prone as a culprit 21.1%. Proximal culprit LAD 63.5% and RCA 55.6% had significantly higher incidence, mid culprit LC× 53.9% had significantly higher incidence. ST-elevation acute coronary syndrome (STE-ACS) was significantly more prevalent in culprit LAD 76.7%. Non-STE-ACS was significantly more prevalent in culprit LC× 56.5% and RCA 55.6%. Conclusion: LAD tends to carry more than one culprit lesion, more to be proximal. Risk factors responsible for instability and sheer stress (uncontrolled diabetes mellitus, uncontrolled hypertension, heavy smoking) were more prevalent between patients with LCx as a culprit followed by RCA in Egyptian; this may throw the light on the need for aggressive control of these risk factors to reduce vulnerability in these patients.
背景:沿冠状树可能存在冠状动脉血栓形成的高概率区。我们的目的是确定患者中重要冠状动脉病变的性质和分布。方法:本研究纳入529例疑似或确诊冠心病(CAD)行冠状动脉造影的患者,根据冠状动脉病变分布分为3组:左前降支(LAD)组(305例)、左旋支(LCx)组(148例)和右冠状动脉(RCA)组(181例)。结果:无显著病变169例(31.9%),单支病变166例(31.4%),显著性LAD病变305例(57.5%)的发生率显著高于近端病变52.4%,LAD病变更容易成为罪魁祸首血管的发生率为47.5%,LCx病变发生率最低,为148例(27.9%),最低为罪魁祸首血管的发生率为21.1%。近端罪魁祸首LAD的发生率为63.5%,RCA的发生率为55.6%,中端罪魁祸首lcx的发生率为53.9%。st段抬高急性冠状动脉综合征(STE-ACS)在罪魁祸首LAD中更为普遍(76.7%)。非ste - acs在罪魁祸首lcx56.5%和RCA 55.6%中更为普遍。结论:LAD有多发病灶的趋势,且多发于近端。导致不稳定和纯粹压力的危险因素(不受控制的糖尿病、不受控制的高血压、大量吸烟)在以LCx为罪魁祸首的患者中更为普遍,然后是埃及的RCA;这可能表明需要积极控制这些危险因素,以减少这些患者的易感性。
{"title":"Understanding the status of the Egyptian coronary lesions: Lesion location and vulnerability","authors":"I. El-Dosouky, B. Nashy, H. Abomandour","doi":"10.4103/jicc.jicc_17_21","DOIUrl":"https://doi.org/10.4103/jicc.jicc_17_21","url":null,"abstract":"Background: High-probability zones of coronary thrombosis may exist along the coronary tree. We aimed to determine the nature and distribution of significant coronary lesions among our patients. Methods: This study included 529 patients, for whom coronary angiography was done for suspected or proved coronary artery disease (CAD), they were divided into three groups according to the distribution of the coronary lesions: left anterior descending (LAD) group (n = 305) with significant LAD lesion, left circumflex (LCx) group (n = 148) with significant LCx lesion and right coronary artery (RCA) group (n = 181) with significant RCA lesion. Results: One hundred and sixty-nine (31.9%) had nonsignificant lesion, 166 (31.4%) had single-vessel disease, with significantly higher incidence of significant LAD lesion 305 (57.5%) which were proximal 52.4%, LAD lesions were more prone to be the culprit vessel 47.5%, LCx was the least vessel with significant lesion 148 (27.9%), and the least to be prone as a culprit 21.1%. Proximal culprit LAD 63.5% and RCA 55.6% had significantly higher incidence, mid culprit LC× 53.9% had significantly higher incidence. ST-elevation acute coronary syndrome (STE-ACS) was significantly more prevalent in culprit LAD 76.7%. Non-STE-ACS was significantly more prevalent in culprit LC× 56.5% and RCA 55.6%. Conclusion: LAD tends to carry more than one culprit lesion, more to be proximal. Risk factors responsible for instability and sheer stress (uncontrolled diabetes mellitus, uncontrolled hypertension, heavy smoking) were more prevalent between patients with LCx as a culprit followed by RCA in Egyptian; this may throw the light on the need for aggressive control of these risk factors to reduce vulnerability in these patients.","PeriodicalId":100789,"journal":{"name":"Journal of Indian College of Cardiology","volume":"53 1","pages":"49 - 54"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77923228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
QT-dispersion and major adverse cardiovascular events prediction after percutaneous coronary intervention in patients with Type 2 diabetes mellitus 2型糖尿病患者经皮冠状动脉介入治疗后qt离散度及主要不良心血管事件预测
Pub Date : 2022-04-01 DOI: 10.4103/jicc.jicc_53_21
Shaimaa Wageeh, I. El-Dosouky, Arafa M. Elshabrawy, Rasha H Omar, Shimaa Zein
Objectives: The objective of this study investigated the relation between QT-dispersion (QTd) and both number of coronary artery disease and major adverse cardiovascular events (MACEs) among patients with type 2 diabetes after elective percutaneous coronary intervention (PCI). Methods: One hundred ischemic heart disease patients undergoing elective coronary angioplasty were included; 49 patients with diabetes (group I) and 51 patients without diabetes mellitus (group II). Based on the QTd parameter after PCI, both groups were subdivided into tertiles. Angiographic, electrocardiographic parameters, and MACE were compared. Results: Both QTd after PCI and delta QTd were correlated to the number of diseased coronary arteries and MACE in patients with diabetes compared to patients without diabetes. QTd was longer in patients with diabetes developing MACE than those without MACE (r = −0.31, P = 0.04). Conclusion: QTd after PCI and delta QTd are the independent predictors of MACE in patients with type 2 diabetes.
目的:探讨2型糖尿病患者择期经皮冠状动脉介入治疗(PCI)后qt离散度(QTd)与冠状动脉疾病数量和主要不良心血管事件(mace)的关系。方法:择期行冠状动脉成形术的缺血性心脏病患者100例;糖尿病患者49例(I组),非糖尿病患者51例(II组)。根据PCI术后QTd参数将两组再细分为各组。比较血管造影、心电图参数和MACE。结果:与非糖尿病患者相比,糖尿病患者PCI术后QTd和δ QTd均与冠脉病变数和MACE相关。发生MACE的糖尿病患者的QTd比未发生MACE的糖尿病患者更长(r = - 0.31, P = 0.04)。结论:PCI术后QTd和δ QTd是2型糖尿病患者MACE的独立预测因子。
{"title":"QT-dispersion and major adverse cardiovascular events prediction after percutaneous coronary intervention in patients with Type 2 diabetes mellitus","authors":"Shaimaa Wageeh, I. El-Dosouky, Arafa M. Elshabrawy, Rasha H Omar, Shimaa Zein","doi":"10.4103/jicc.jicc_53_21","DOIUrl":"https://doi.org/10.4103/jicc.jicc_53_21","url":null,"abstract":"Objectives: The objective of this study investigated the relation between QT-dispersion (QTd) and both number of coronary artery disease and major adverse cardiovascular events (MACEs) among patients with type 2 diabetes after elective percutaneous coronary intervention (PCI). Methods: One hundred ischemic heart disease patients undergoing elective coronary angioplasty were included; 49 patients with diabetes (group I) and 51 patients without diabetes mellitus (group II). Based on the QTd parameter after PCI, both groups were subdivided into tertiles. Angiographic, electrocardiographic parameters, and MACE were compared. Results: Both QTd after PCI and delta QTd were correlated to the number of diseased coronary arteries and MACE in patients with diabetes compared to patients without diabetes. QTd was longer in patients with diabetes developing MACE than those without MACE (r = −0.31, P = 0.04). Conclusion: QTd after PCI and delta QTd are the independent predictors of MACE in patients with type 2 diabetes.","PeriodicalId":100789,"journal":{"name":"Journal of Indian College of Cardiology","volume":"17 1","pages":"55 - 59"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80847577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Takayasu aortoarteritis masquerading left ventricular noncompaction syndrome 伪装成左心室不压实综合征的高须大动脉炎
Pub Date : 2022-01-01 DOI: 10.4103/jicc.jicc_7_21
Y. Gokhale, A. Patankar, A. Mahajan, Vikrant Firke
We report an interesting case of a 20-year-old man who was admitted in intensive cardiac care unit with congestive cardiac failure along with thromboembolic manifestations and a raised erythrocyte sedimentation rate. On the basis of two-dimensional echocardiography, he was diagnosed as left ventricular noncompaction syndrome. However, cardiac magnetic resonance imaging (MRI) ruled out noncompaction. After extensive workup, the patient was diagnosed with Takayasu aortoarteritis. Post therapy, the patient has normal cardiac function and cardiac MRI without thromboembolic event in 8 years' follow-up.
我们报告一个有趣的情况下,一个20岁的男子谁住在心脏重症监护病房充血性心力衰竭伴随血栓栓塞的表现和红细胞沉降率升高。经二维超声心动图诊断为左心室非压实综合征。然而,心脏磁共振成像(MRI)排除了非压实。经过广泛的检查,患者被诊断为高松大动脉炎。治疗后8年随访,患者心功能正常,心脏MRI无血栓栓塞事件。
{"title":"Takayasu aortoarteritis masquerading left ventricular noncompaction syndrome","authors":"Y. Gokhale, A. Patankar, A. Mahajan, Vikrant Firke","doi":"10.4103/jicc.jicc_7_21","DOIUrl":"https://doi.org/10.4103/jicc.jicc_7_21","url":null,"abstract":"We report an interesting case of a 20-year-old man who was admitted in intensive cardiac care unit with congestive cardiac failure along with thromboembolic manifestations and a raised erythrocyte sedimentation rate. On the basis of two-dimensional echocardiography, he was diagnosed as left ventricular noncompaction syndrome. However, cardiac magnetic resonance imaging (MRI) ruled out noncompaction. After extensive workup, the patient was diagnosed with Takayasu aortoarteritis. Post therapy, the patient has normal cardiac function and cardiac MRI without thromboembolic event in 8 years' follow-up.","PeriodicalId":100789,"journal":{"name":"Journal of Indian College of Cardiology","volume":"10 1","pages":"40 - 42"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87869453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical coherence tomography-guided deferred stenting in acute coronary syndromes 光学相干断层扫描引导的急性冠状动脉综合征延期支架置入
Pub Date : 2022-01-01 DOI: 10.4103/jicc.jicc_87_20
I. Sathyamurthy, Srinivasan Kanthallu, V. PaulPandi
Acute coronary syndromes were thought to be due to plaque rupture with superimposed thrombus. With optical coherence tomography plaque erosion (PE) can be detected in one third of cases. In young patients without major risk factors one can suspect PE. We are reporting one such case in whom stenting was deferred.
急性冠脉综合征被认为是由于斑块破裂合并血栓。光学相干断层扫描可以检测斑块侵蚀(PE)在三分之一的情况下。在没有主要危险因素的年轻患者中,可以怀疑PE。我们正在报告一个这样的病例,其中支架植入被推迟。
{"title":"Optical coherence tomography-guided deferred stenting in acute coronary syndromes","authors":"I. Sathyamurthy, Srinivasan Kanthallu, V. PaulPandi","doi":"10.4103/jicc.jicc_87_20","DOIUrl":"https://doi.org/10.4103/jicc.jicc_87_20","url":null,"abstract":"Acute coronary syndromes were thought to be due to plaque rupture with superimposed thrombus. With optical coherence tomography plaque erosion (PE) can be detected in one third of cases. In young patients without major risk factors one can suspect PE. We are reporting one such case in whom stenting was deferred.","PeriodicalId":100789,"journal":{"name":"Journal of Indian College of Cardiology","volume":"262 1","pages":"37 - 39"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75850527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment strategies of hypokalemia in heart failure 心力衰竭低钾血症的治疗策略
Pub Date : 2022-01-01 DOI: 10.4103/jicc.jicc_62_21
Kavya Surendran, B. Joseph, J. Vilapurathu
Sudden cardiac death is estimated to affect approximately three million people worldwide each year. Substrates and triggers often play a complex role in these deaths. Among the heart cells, disturbed potassium homeostasis is one such trigger. Hypokalemia and transient drops in potassium concentration are significant issues. Heart failure (HF) therapy is increasingly complicated by maintaining normal serum potassium (K+) homeostasis. As a result of the use of loop diuretics hypokalemia has become a severe and feared side effect of treatment. Hypokalemia in HF also indicates greater neurohormonal activity and progression of disease. Personalized drug use and monitoring of electrolytes are crucial for successful treatment. The lowest dose of diuretic necessary to maintain euvolemia should be prescribed to HF patients with symptoms (New York Heart Association Class III-IV). Aldosterone receptor antagonists, spironolactone can be used to treat mild hypokalemia. For more severe, K + supplement is recommended. Levels should be routinely monitored and kept between 4.0 and 5.5 mEq/l.
据估计,全世界每年约有300万人死于心源性猝死。底物和触发因素通常在这些死亡中起着复杂的作用。在心脏细胞中,钾稳态紊乱就是这样一个触发因素。低钾血症和短暂的钾浓度下降是重要的问题。心衰(HF)的治疗越来越复杂,需要维持正常的血清钾(K+)稳态。由于循环利尿剂的使用,低钾血症已成为治疗的严重和可怕的副作用。心衰患者的低钾血症也表明神经激素活性和疾病的进展。个体化用药和监测电解质是成功治疗的关键。对于有症状的心衰患者,应给予维持血容量所需的最低剂量利尿剂(纽约心脏协会III-IV类)。醛固酮受体拮抗剂,螺内酯可用于治疗轻度低钾血症。对于严重的,建议补充K +。水平应定期监测,并保持在4.0和5.5毫微克/升之间。
{"title":"Treatment strategies of hypokalemia in heart failure","authors":"Kavya Surendran, B. Joseph, J. Vilapurathu","doi":"10.4103/jicc.jicc_62_21","DOIUrl":"https://doi.org/10.4103/jicc.jicc_62_21","url":null,"abstract":"Sudden cardiac death is estimated to affect approximately three million people worldwide each year. Substrates and triggers often play a complex role in these deaths. Among the heart cells, disturbed potassium homeostasis is one such trigger. Hypokalemia and transient drops in potassium concentration are significant issues. Heart failure (HF) therapy is increasingly complicated by maintaining normal serum potassium (K+) homeostasis. As a result of the use of loop diuretics hypokalemia has become a severe and feared side effect of treatment. Hypokalemia in HF also indicates greater neurohormonal activity and progression of disease. Personalized drug use and monitoring of electrolytes are crucial for successful treatment. The lowest dose of diuretic necessary to maintain euvolemia should be prescribed to HF patients with symptoms (New York Heart Association Class III-IV). Aldosterone receptor antagonists, spironolactone can be used to treat mild hypokalemia. For more severe, K + supplement is recommended. Levels should be routinely monitored and kept between 4.0 and 5.5 mEq/l.","PeriodicalId":100789,"journal":{"name":"Journal of Indian College of Cardiology","volume":"T153 1","pages":"1 - 7"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82636240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of middle aortic syndrome in takayasu arteritis with left ventricle dysfunction and heart failure 高须动脉炎合并左心室功能障碍心力衰竭并发中主动脉综合征1例
Pub Date : 2022-01-01 DOI: 10.4103/jicc.jicc_4_21
D. Thakkar, S. Shankar, Ramnaresh Soudri, T. Babu Reddy, C. Nagesh, B. Srinivas, C. Manjunath
Left ventricular dysfunction is an uncommon complication of Takayasu arteritis (TA) with a prevalence of about 10%–15%. We report a case of a 27-year-old girl who presented with dyspnea, bipedal edema, loss of weight, and easy fatigability for 3 months. Patient also developed right hemiparesis 3 months ago. Computed tomography of the brain was suggestive of the left temporal infarct, on evaluation she was diagnosed as left ventricle (LV) dysfunction and she was treated for CVA and heart failure. Clinical examination revealed the absence of the left upper limb and bilateral lower limb pulses with right upper limb hypertension. Echocardiography revealed severe LV dysfunction (ejection function ~20%). Computed tomography angiogram and other inflammatory markers confirmed the diagnosis of TA and revealed the presence of coaraction of the thoracic and abdominal aorta. Coaractoplasty was done, and immunosuppressant therapy with oral prednisolone and weekly oral methotrexate was started. On follow-up, patient is asymptomatic with improved LV function. Any patient with LV dysfunction or dilated cardiomyopathy, reversible causes have to be ruled out and TA has to be thought of as a differential diagnosis particularly in young females. Checking of all four limbs pulses and blood pressure is strictly recommended. TA is a systemic vasculopathy that can progress to cause vital organ ischemia. Therefore, early diagnosis and management as well as long-term follow-up is recommended.
左心室功能障碍是高须动脉炎(TA)的罕见并发症,患病率约为10%-15%。我们报告一个27岁的女孩,她表现为呼吸困难,两足水肿,体重减轻,容易疲劳3个月。患者3个月前也出现右半瘫。脑部计算机断层扫描提示左侧颞叶梗死,经评估诊断为左心室功能障碍,并接受CVA和心力衰竭治疗。临床检查发现左上肢和双下肢脉搏缺失,伴右上肢高血压。超声心动图显示严重左室功能障碍(射血功能~20%)。计算机断层血管造影和其他炎症标志物证实了TA的诊断,并显示存在胸主动脉和腹主动脉收缩。进行了胸廓成形术,并开始口服强的松龙和每周口服甲氨蝶呤的免疫抑制治疗。随访时,患者无症状,左室功能改善。任何左室功能障碍或扩张型心肌病患者,可逆的原因必须排除,TA必须被认为是一种鉴别诊断,特别是在年轻女性中。严格建议检查四肢脉搏和血压。TA是一种全身性血管病变,可发展为重要器官缺血。因此,建议早期诊断和治疗,并长期随访。
{"title":"A case of middle aortic syndrome in takayasu arteritis with left ventricle dysfunction and heart failure","authors":"D. Thakkar, S. Shankar, Ramnaresh Soudri, T. Babu Reddy, C. Nagesh, B. Srinivas, C. Manjunath","doi":"10.4103/jicc.jicc_4_21","DOIUrl":"https://doi.org/10.4103/jicc.jicc_4_21","url":null,"abstract":"Left ventricular dysfunction is an uncommon complication of Takayasu arteritis (TA) with a prevalence of about 10%–15%. We report a case of a 27-year-old girl who presented with dyspnea, bipedal edema, loss of weight, and easy fatigability for 3 months. Patient also developed right hemiparesis 3 months ago. Computed tomography of the brain was suggestive of the left temporal infarct, on evaluation she was diagnosed as left ventricle (LV) dysfunction and she was treated for CVA and heart failure. Clinical examination revealed the absence of the left upper limb and bilateral lower limb pulses with right upper limb hypertension. Echocardiography revealed severe LV dysfunction (ejection function ~20%). Computed tomography angiogram and other inflammatory markers confirmed the diagnosis of TA and revealed the presence of coaraction of the thoracic and abdominal aorta. Coaractoplasty was done, and immunosuppressant therapy with oral prednisolone and weekly oral methotrexate was started. On follow-up, patient is asymptomatic with improved LV function. Any patient with LV dysfunction or dilated cardiomyopathy, reversible causes have to be ruled out and TA has to be thought of as a differential diagnosis particularly in young females. Checking of all four limbs pulses and blood pressure is strictly recommended. TA is a systemic vasculopathy that can progress to cause vital organ ischemia. Therefore, early diagnosis and management as well as long-term follow-up is recommended.","PeriodicalId":100789,"journal":{"name":"Journal of Indian College of Cardiology","volume":"22 1","pages":"28 - 30"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75069741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary slow flow/no-reflow: Revisited 冠状动脉慢血流/无血流:再访
Pub Date : 2022-01-01 DOI: 10.4103/JICC.JICC_72_20
Srinivasan Kanthallu, I. Sathyamurthy
No-reflow is defined as failure to restore normal myocardial perfusion despite removal of mechanical obstruction in the epicardial coronary arteries. This phenomenon is associated with high risk of major adverse cardiac events, recurrent heart failure, arrhythmias, and death. The degree of reperfusion injury depends on the duration of preceding myocardial ischemia, infarct size, procedure variables, and patient characteristics. This complication predominantly occurs during percutaneous coronary intervention for acute coronary syndrome. Cardiac magnetic resonance imaging is the gold standard noninvasive method for assessing this phenomenon. Conditions such as flow-limiting dissection, in situ thrombosis, severe spasm, or high-grade residual stenosis should be excluded prior to making a diagnosis of no-reflow phenomenon. The management of no-reflow should be personalized according to the predominant mechanisms contributing to the microvascular obstruction.
无回流定义为尽管去除心外膜冠状动脉的机械性阻塞,但仍不能恢复正常的心肌灌注。这种现象与主要心脏不良事件、复发性心力衰竭、心律失常和死亡的高风险相关。再灌注损伤的程度取决于先前心肌缺血的持续时间、梗死面积、手术变量和患者特征。这种并发症主要发生在急性冠状动脉综合征的经皮冠状动脉介入治疗期间。心脏磁共振成像是评估这种现象的金标准无创方法。在诊断无回流现象之前,应排除限流夹层、原位血栓形成、严重痉挛或高度残留狭窄等情况。无回流治疗应根据微血管阻塞的主要机制进行个性化治疗。
{"title":"Coronary slow flow/no-reflow: Revisited","authors":"Srinivasan Kanthallu, I. Sathyamurthy","doi":"10.4103/JICC.JICC_72_20","DOIUrl":"https://doi.org/10.4103/JICC.JICC_72_20","url":null,"abstract":"No-reflow is defined as failure to restore normal myocardial perfusion despite removal of mechanical obstruction in the epicardial coronary arteries. This phenomenon is associated with high risk of major adverse cardiac events, recurrent heart failure, arrhythmias, and death. The degree of reperfusion injury depends on the duration of preceding myocardial ischemia, infarct size, procedure variables, and patient characteristics. This complication predominantly occurs during percutaneous coronary intervention for acute coronary syndrome. Cardiac magnetic resonance imaging is the gold standard noninvasive method for assessing this phenomenon. Conditions such as flow-limiting dissection, in situ thrombosis, severe spasm, or high-grade residual stenosis should be excluded prior to making a diagnosis of no-reflow phenomenon. The management of no-reflow should be personalized according to the predominant mechanisms contributing to the microvascular obstruction.","PeriodicalId":100789,"journal":{"name":"Journal of Indian College of Cardiology","volume":"66 1","pages":"8 - 13"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74476413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Indian College of Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1